A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-6.17%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$352M
AUM Growth
+$352M
Cap. Flow
+$18.9M
Cap. Flow %
5.35%
Top 10 Hldgs %
95.16%
Holding
20
New
–
Increased
3
Reduced
–
Closed
–

Top Buys

1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
$14M
2
PHAT icon
Phathom Pharmaceuticals
PHAT
$3.15M
3
SLNO icon
Soleno Therapeutics
SLNO
$1.7M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 98.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$101M 28.51% 4,168,718 – –
VERA icon
2
Vera Therapeutics
VERA
$1.38B
$69.3M 19.66% 2,960,231 – –
ACET icon
3
Adicet Bio
ACET
$59.9M
$42.2M 11.96% 2,115,385 – –
SRRA
4
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$42.1M 11.95% 1,314,012 +437,356 +50% +$14M
JSPR icon
5
Jasper Therapeutics
JSPR
$45.5M
$19.5M 5.54% 5,628,558 – –
PHAT icon
6
Phathom Pharmaceuticals
PHAT
$864M
$19.5M 5.53% 1,435,106 +231,971 +19% +$3.15M
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$18.9M 5.36% 4,822,114 – –
VRNA
8
Verona Pharma
VRNA
$9.16B
$12.1M 3.44% 2,457,499 – –
OKUR
9
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$6.08M 1.72% 2,073,957 – –
SIEN
10
DELISTED
Sientra, Inc.
SIEN
$5.19M 1.47% 2,349,827 – –
SLNO icon
11
Soleno Therapeutics
SLNO
$3.6B
$3.97M 1.12% 18,022,602 +7,720,000 +75% +$1.7M
NCNA
12
NuCana
NCNA
$6.09M
$3.28M 0.93% 3,333,333 – –
PRTK
13
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.08M 0.87% 1,041,131 – –
XCUR icon
14
Exicure
XCUR
$35.4M
$1.37M 0.39% 6,977,000 – –
MTEM
15
DELISTED
Molecular Templates, Inc.
MTEM
$690K 0.2% 200,000 – –
SYRE icon
16
Spyre Therapeutics
SYRE
$996M
$553K 0.16% 240,500 – –
CBAY
17
DELISTED
Cymabay Therapeutics
CBAY
$406K 0.12% 131,036 – –
OBSV
18
DELISTED
ObsEva SA Ordinary Shares
OBSV
$133K 0.04% 87,999 – –
OCGN icon
19
Ocugen
OCGN
$319M
$23K 0.01% 7,111 – –